IMAC HOLDINGS INC (IMAC) Stock Price & Overview

NASDAQ:IMAC • US44967K1043

Current stock price

1.01 USD
+0.02 (+2%)
Last:

The current stock price of IMAC is 1.01 USD. Today IMAC is up by 2%. In the past month the price increased by 2.54%. In the past year, price decreased by -35.67%.

IMAC Key Statistics

52-Week Range0.75 - 1.65
Current IMAC stock price positioned within its 52-week range.
1-Month Range0.92 - 1.11
Current IMAC stock price positioned within its 1-month range.
Market Cap
26.75M
P/E
N/A
Fwd P/E
N/A
EPS (TTM)
-0.38
Dividend Yield
N/A

IMAC Stock Performance

Today
+2%
1 Week
+4.30%
1 Month
+2.54%
3 Months
+26.27%
Longer-term
6 Months -17.89%
1 Year -35.67%
2 Years N/A
3 Years N/A
5 Years N/A
10 Years N/A

IMAC Stock Chart

IMAC HOLDINGS INC / IMAC Daily stock chart

IMAC Technical Analysis

ChartMill assigns a technical rating of 5 / 10 to IMAC. When comparing the yearly performance of all stocks, IMAC turns out to be only a medium performer in the overall market: it outperformed 43.31% of all stocks.


Chartmill TA Rating
Chartmill Setup Rating

IMAC Fundamental Analysis

ChartMill assigns a fundamental rating of 3 / 10 to IMAC. Both the profitability and financial health of IMAC have multiple concerns.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

IMAC Earnings

Next Earnings DateAug 23, 2022
Last Earnings DateMay 12, 2022
PeriodQ1 / 2022
EPS Reported-$0.12
Revenue Reported
EPS Surprise -30.72%
Revenue Surprise -18.75%

IMAC Forecast & Estimates

8 analysts have analysed IMAC and the average price target is 3.59 USD. This implies a price increase of 255.15% is expected in the next year compared to the current price of 1.01.

For the next year, analysts expect an EPS growth of 2.98% and a revenue growth 21.45% for IMAC


Analysts
Analysts80
Price Target3.59 (255.45%)
EPS Next Y2.98%
Revenue Next Year21.45%

IMAC Groups

Sector & Classification

Index Membership

IMAC Financial Highlights

Over the last trailing twelve months IMAC reported a non-GAAP Earnings per Share(EPS) of -0.38. The EPS increased by 13.64% compared to the year before.


Income Statements
Revenue(TTM)15.22M
Net Income(TTM)-11.71M
Industry RankSector Rank
PM (TTM) -76.98%
ROA -48.41%
ROE N/A
Debt/Equity 0.01
Chartmill High Growth Momentum
EPS Q2Q%20%
Sales Q2Q%27.29%
EPS 1Y (TTM)13.64%
Revenue 1Y (TTM)21.05%

IMAC Ownership

Ownership
Inst Owners11.86%
Shares26.49M
Float20.45M
Ins Owners8.88%
Short Float %N/A
Short RatioN/A

IMAC Competitors/Peers

The largest stocks on the US markets in the "Health Care Facilities" sub-industry
Full List
SymbolCompany NameTechnical RatingFundamental RatingFPEMarket Cap
HCA HCA HEALTHCARE INC17.46119.096B
THC TENET HEALTHCARE CORP13.2719.542B
ENSG ENSIGN GROUP INC/THE27.3512.108B
UHS UNIVERSAL HEALTH SERVICES-B8.0711.637B
EHC ENCOMPASS HEALTH CORP16.689.972B
PACS PACS GROUP INC16.745.295B
BKD BROOKDALE SENIOR LIVING INC N/A3.305B
CON CONCENTRA GROUP HOLDINGS PAR15.062.821B
NHC NATIONAL HEALTHCARE CORP N/A2.422B
ACHC ACADIA HEALTHCARE CO INC15.652.226B
SEM SELECT MEDICAL HOLDINGS CORP12.452.014B
SGRY SURGERY PARTNERS INC16.511.648B
ARDT ARDENT HEALTH INC6.851.323B

About IMAC

Company Profile

IMAC logo image IMAC Holdings, Inc. provides medical services through integrated medicine and chiropractic regeneration centers. The company is headquartered in Brentwood, Tennessee and currently employs 154 full-time employees. The company went IPO on 2019-02-13. The firm provides movement, orthopedic and neurological therapies through its chain of Innovative Medical Advancements and Care (IMAC) Regeneration Centers. The Company, through its outpatient medical clinics, provide conservative, non-invasive medical treatments to help patients with back pain, knee pain, joint pain, ligament and tendon damage, and other related soft tissue conditions. Its BACKSPACE retail spine health and wellness treatment centers deliver chiropractic care within Walmart locations. The firm is also conducting a Phase I clinical trial evaluating a mesenchymal stem cell therapy candidate for bradykinesia due to Parkinson's disease. The firm operates approximately 17 outpatient medical clinics in six states and four BackSpace locations in two states of United States.

Company Info

IPO: 2019-02-13

IMAC HOLDINGS INC

1605 Westgate Cir

Brentwood TENNESSEE 37027 US

CEO: Jeffrey S. Ervin

Employees: 154

IMAC Company Website

Phone: 18442664622.0

IMAC HOLDINGS INC / IMAC FAQ

What does IMAC HOLDINGS INC do?

IMAC Holdings, Inc. provides medical services through integrated medicine and chiropractic regeneration centers. The company is headquartered in Brentwood, Tennessee and currently employs 154 full-time employees. The company went IPO on 2019-02-13. The firm provides movement, orthopedic and neurological therapies through its chain of Innovative Medical Advancements and Care (IMAC) Regeneration Centers. The Company, through its outpatient medical clinics, provide conservative, non-invasive medical treatments to help patients with back pain, knee pain, joint pain, ligament and tendon damage, and other related soft tissue conditions. Its BACKSPACE retail spine health and wellness treatment centers deliver chiropractic care within Walmart locations. The firm is also conducting a Phase I clinical trial evaluating a mesenchymal stem cell therapy candidate for bradykinesia due to Parkinson's disease. The firm operates approximately 17 outpatient medical clinics in six states and four BackSpace locations in two states of United States.


What is the current price of IMAC stock?

The current stock price of IMAC is 1.01 USD. The price increased by 2% in the last trading session.


Does IMAC stock pay dividends?

IMAC does not pay a dividend.


What is the ChartMill technical and fundamental rating of IMAC stock?

IMAC has a ChartMill Technical rating of 5 out of 10 and a ChartMill Fundamental rating of 3 out of 10.


When does IMAC HOLDINGS INC (IMAC) report earnings?

IMAC HOLDINGS INC (IMAC) will report earnings on 2022-08-23, before the market open.